ARTL: Artelo Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.65
Enterprise Value ($M) -0.71
Book Value ($M) 6.36
Book Value / Share 1.97
Price / Book 0.57
NCAV ($M) 4.21
NCAV / Share 1.30
Price / NCAV 0.87

Profitability (mra)
Return on Invested Capital (ROIC) -1.41
Return on Assets (ROA) -0.59
Return on Equity (ROE) -0.63

Liquidity (mrq)
Quick Ratio 7.15
Current Ratio 7.15

Balance Sheet (mrq) ($M)
Current Assets 4.99
Assets 7.14
Liabilities 0.78
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 4,606 13,830 33.30
2024-11-21 814 17,536 4.64
2024-11-20 8,122 15,552 52.22
2024-11-19 14,220 37,163 38.26
2024-11-18 87,523 215,612 40.59

(click for more detail)

Similar Companies
APRE – Aprea Therapeutics, Inc. APTO – Aptose Biosciences Inc.
APVO – Aptevo Therapeutics Inc. ASNS – Actelis Networks, Inc.
ASRT – Assertio Holdings, Inc.


Financial data and stock pages provided by
Fintel.io